Novo Nordisk launches Anti-Diabetic drug Semaglutide in ‘game-changing’ Pill form
Summary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
Summary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
Remogliflozin was discovered and developed by Japanese firm Kissei Pharmaceutical Co and subsequently developed by GlaxoSmithKline Plc and BHV Pharma, a…